Serum Sodium and Gut Klebsiella Are Positively Related to Osteoporosis

Xiuhong Cao,Pengbing Hua,Yongjun Zhu,Hongwang Cui,Fabiao Yu,Tongmeng JiangFirst published: 02 April 2026https://doi.org/10.1002/cbf.70207Digital Object Identifier (DOI)

Cell Biochemistry and Function

Volume44, Issue4  April 2026  e70207

ABSTRACT

Emerging evidence suggests a link between gut microbiota dysbiosis and osteoporosis. However, specific bacterial taxa and metabolic correlates in human osteoporosis remain poorly characterized. This study explored gut microbial profiles and serum biochemical markers in osteoporosis patients compared to non-osteoporosis individuals in Hainan, China. Fecal samples and serum biochemistry, including liver function, kidney function, lipid profiles, and ion concentrations, were analyzed in six osteoporosis patients and six non-osteoporosis individuals. Gut microbiota composition was assessed via 16S rDNA gene sequencing. Differential abundance analysis and linear discriminant analysis effect size (LEfSe) were performed to identify biomarkers. Osteoporosis patients exhibited significantly higher serum sodium levels (143.31 ± 1.40 mmol/L vs. 140.00 ± 2.60 mmol/L, p < 0.05) and reduced HDL cholesterol (1.03 ± 0.14 vs. 1.33 ± 0.09 mmol/L, p < 0.05). Microbiota profiling revealed 11 enriched and seven depleted bacteria in patients by LEfSe analysis. Notably, Klebsiella showed the highest relative abundance increase in osteoporosis patients, while Megamonas abundance was significantly reduced as indicated by square root of the indicator value (sqrtIVt). This pilot study identifies elevated serum sodium and gut Klebsiella enrichment as potential metabolic and microbial signatures of osteoporosis in the Hainan population. These findings suggest that modulation of gut microbiota and sodium management could be explored as preventive strategies. Larger, multiethnic cohorts and mechanistic studies are needed to validate these biomarkers and elucidate causality.

Summary

• This study holds notable significance as it bridges gaps in human-focused research on gut microbiota-serum sodium-osteoporosis crosstalk.While the gut-bone axis link is established, few human studies explore serum traits and microbial metabolism in osteoporosis.Our findings in elevated serum sodium and altered gut microbiota in osteoporosis patients uncover novel biomarkers, which advance understanding of disease pathogenesis, especially in the Hainan population, and inform targeted prevention via probiotics/prebiotics/postbiotics.By identifying species-specific microbial changes and serum sodium associations, the study lays groundwork for translating gut microbiota modulation into clinical strategies against osteoporosis.

转载本文请联系原作者获取授权，同时请注明本文来自于法标科学网博客。
链接地址：https://blog.sciencenet.cn/blog-2438823-1532271.html

上一篇：fluorescent probe for hypoxic stress
下一篇：fluorescent probe for superoxide anion